While some richer nations dither over how to deal with biotech farming innovations, scientists in lower and middle income countries are seizing the opportunity to give agriculture a targeted genomic reboot.
Brexit has been a disaster for the UK. It has not spurred the great economic revival that many of the Brexiters claimed it would. And many studies have indicated it will make the UK poorer over the long-term and deter investment.
Yield10 Bioscience says it has exercised its option to finalize a global, commercial license to advanced omega-3 production technology from UK based Rothamsted Research.